BIOA

Bioage Labs Stock Analysis

AI Rating

Low
  • Quality3/10
  • Growth 2/10
  • Value 0/10
Bioage Labs sales and earnings growth
BIOA Growth
Fair
  • Revenue Y/Y 474.31%
  • EPS Y/Y -1946.15%
  • FCF Y/Y -64.11%
Bioage Labs gross and profit margin trends
BIOA Profitability
Neutral
  • Gross margin 100.00%
  • EPS margin -871.80%
  • ROIC 5Y 0.00%
Bioage Labs net debt vs free cash flow
BIOA Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage -186.0

Bioage Labs stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks